This meeting took place in 2018

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Progress and Pathways Toward an Effective HIV Vaccine (J6)

Organizer(s) M. Juliana McElrath, Pamela J. Bjorkman and Beatrice H. Hahn
January 28—February 1, 2018
Fairmont Banff Springs • Banff, Alberta Canada
Discounted Abstract Deadline: Oct 4, 2017
Abstract Deadline: Nov 2, 2017
Scholarship Deadline: Oct 4, 2017
Discounted Registration Deadline: Dec 6, 2017

Sponsored by Pfizer Inc.
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

Summary of Meeting:
After three decades, HIV-1 continues to afflict and kill millions of people worldwide. A safe and effective vaccine that elicits potent and durable protective immunity has the greatest prospect to end the AIDS epidemic. Development of an HIV vaccine has proven scientifically challenging, as evidenced by only one weakly efficacious regimen after evaluation of four distinct regimens. However, the field is in a phase of rapid growth and innovation for new vaccine strategies that hold promise for efficacy. Such emerging, novel findings will be the focus of this meeting, and will include: 1) Technological advances in structural properties of the HIV-1 envelope glycoprotein and its recognition and interactions with potent neutralizing antibodies; 2) Improved animal model platforms that can better mimic the transmitted founder HIV-1 strains and human immune recognition; 3) Greater understanding of host B and T cell immunobiology in the lymphoid germinal centers that is critical to optimize candidate vaccines and immunization regimens; 4) New tools for interrogating human immune repertoire; and 5) highlights of promising strategies in first in human to efficacy studies. Emphasis will be placed on unpublished findings and advances specifically relevant to human immunology and HIV vaccine targets.

View Meeting Program


National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Omolara Olujimi Baiyegunhi
University of KwaZulu-Natal, South Africa

Christopher O. Barnes
California Institute of Technology, USA

Sushma Boppana
University of Alabama at Birmingham, USA

Kimberly M. Cirelli
La Jolla Institute for Allergy and Immunology, USA

Christopher Andrew Cottrell
The Scripps Research Institute, USA

Allen Lin
Harvard University, USA

Matthias Georg Pauthner
The Scripps Research Institute, USA

Daniel Reeves
Fred Hutchinson Cancer Research Center, USA

Jonathan Richard
Centre de Recherche du CHUM, Canada

Marlies Melanie Van Haaren
Amsterdam Medical Center, Netherlands

Chengcheng Zou
Center for AIDS Research, Kumamoto University, Japan

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Funded by Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Olutoyin Omolara Bamigboye
Adeleke University, Nigeria

Lavinia Joy Muyoti Bwisa
University of Nairobi, Kenya

Rajat Desikan
Indian Institute of Science, India

Martin Ositadinma Ifeanyichukwu
Nnamdi Azikiwe University, Nigeria

Samuel Mundia Kariuki
University of Cape Town, South Africa

Christopher Kintu
Makerere University Medical School, Uganda

Dale Kitchin
National Institute for Communicable Diseases, South Africa

Enoch Sekayita Muyanja
International AIDS Vaccine Initiative, Uganda

Sylvia Nanono
MRC/UVRI Uganda Research Unit on AIDS, Uganda

Amobi Emmanuel Nwakaeze
Ebonyi State University, Nigeria

Borna Achieng Nyaoke
Kenya AIDS Vaccine Initiative, Kenya

Simone Irene Richardson
National Institute for Communicable Diseases, South Africa

Shariq Mahmood Usmani
Massachusetts General Hospital, USA

Qian Wang
Tsinghua University, China